Back to results
US 2024/0393320 A1Published application
Platforms for drug tests against synucleinopathy using human brain organoids
AssigneeOkinawa Institute of Science and Technology School Corporation
InventorsJunghyun JO, Hoang-Dai TRAN, Gordon William ARBUTHNOTT
Life of this patent
Estimating the term…
Abstract
The present invention provides human striatal-like organoid (hSLO) similar to a huma striatum, a fusion organoid of hSLO and human midbrain-like organoid (hMLO) having functional connections between the hSLO and hMLO, and method of testing drugs using the organoids culture platform.
Claims17
A method of culturing an embryoid body (EB) such as a human embryoid body, comprising:
- culturing an EB in a first culture medium containing a first factor, wherein the first factor comprises a TGF-β signaling pathway inhibitor and/or Wnt inhibitor such as GSK inhibitor.
An isolated organoid comprising:
- a mature medium spiny neuron (MSN) expressing one or more markers of a mature MSN.
Dependencies are inferred from the claim text.